Moderna’s new influenza vaccine, based on the same mRNA technology used in its COVID-19 vaccine, showed promising results in a major trial.

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer ...

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days. The moves could change what ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

A CDC advisory panel voted 5–1 to recommend only flu vaccines without the preservative thimerosal, a mercury-containing ...

A key vaccine policy advisory group is recommending the public not receive vaccines that have thimerosal, a ...

Dr. Levi and Vicky Pebsworth, a nurse affiliated with an anti-vaccine group, voted against recommending clesrovimab; the ...

A CDC panel’s vote to stop recommending thimerosal-containing flu shots would have limited impact, but it illustrates how the anti-vaccine movement is achieving its goals.